| 8/15/2024 | IG | New Issue: Quest Diagnostics sells $1.85 billion of notes due 2027, 2029, 2034
|
| 8/15/2024 | BKIG | Moody’s gives Quest notes Baa1
|
| 8/15/2024 | BKIG | S&P assigns BBB+ to Quest notes
|
| 8/15/2024 | BKIG | Fitch rates Quest Diagnostics notes BBB
|
| 8/15/2024 | IG | Quest Diagnostics kicks off note offering to fund LifeLabs purchase
|
| 7/3/2024 | BKCAIG | Quest Diagnostics will take on debt to buy LifeLabs for C$1.35 billion
|
| 5/13/2024 | BKIG | Moody's upgrades Quest Diagnostics
|
| 10/30/2023 | IG | New Issue: Quest Diagnostics prices $750 million of 6.4% notes due 2033 at 153 bps spread
|
| 10/30/2023 | BKIG | Fitch gives Quest Diagnostics notes BBB
|
| 10/30/2023 | BKIG | S&P assigns BBB+ to Quest notes
|
| 10/30/2023 | BKIG | Moody’s rates Quest notes Baa2
|
| 10/30/2023 | IG | Quest Diagnostics to price senior notes via five bookrunners
|
| 5/24/2023 | BKIG | Moody’s alters Quest outlook to positive
|
| 5/8/2023 | BKIG | Fitch revises Quest view to positive
|
| 9/28/2021 | SP | New Issue: Citigroup prices $775,000 contingent coupon autocalls on three stocks
|
| 12/26/2020 | SP | New Issue: GS Finance sells $500,000 leveraged basket-linked notes on 37 stocks
|
| 9/2/2020 | SP | New Issue: Goldman prices $1.2 million leveraged basket-linked notes on 20 stocks
|
| 6/18/2020 | SP | New Issue: Goldman prices $7.88 million leveraged basket-linked notes on 62 stocks
|
| 5/26/2020 | SP | New Issue: Goldman prices $2.12 million leveraged buffered basket-linked notes on 26 stocks
|
| 5/11/2020 | EMHYPFPV | Market Commentary: Disney, PayPal, Fiserv, Nutrien, Suncor, ITC, Regency, Quest price
|
| 5/11/2020 | IG | Market Commentary: Disney, PayPal, Fiserv, Nutrien, Suncor, ITC, Regency, Quest price; EBRD, Cades on deck
|
| 5/11/2020 | IG | New Issue: Quest Diagnostics prices $550 million of 2.8% notes due 2031 at 210 bps spread
|
| 5/11/2020 | BKIG | Moody’s assigns Quest notes Baa2
|
| 5/11/2020 | BKIG | Fitch rates Quest notes BBB
|
| 5/11/2020 | IG | Market Commentary: Morning Commentary: Disney, PayPal, Nutrien, Fiserv, Suncor, EBRD, Cades on deck
|
| 5/11/2020 | BKIG | S&P gives Quest notes BBB+
|
| 5/11/2020 | IG | Quest Diagnostics to price senior notes via five bookrunners
|
| 4/28/2020 | SP | New Issue: Goldman prices $910,000 leveraged basket-linked notes on 26 stocks
|
| 4/24/2020 | SP | New Issue: Goldman prices $1.73 million leveraged basket-linked notes on 19 stocks
|
| 4/23/2020 | SP | New Issue: Goldman prices $9.16 million leveraged basket-linked notes on 26 stocks
|
| 4/22/2020 | BKBWIG | Quest may tap high-grade debt markets if it can’t access facilities
|
| 12/9/2019 | EMHYPFPV | Market Commentary: Steel Dynamics, Quest Diagnostics, Welltower, BP Capital price; Apollo markets dollar notes
|
| 12/9/2019 | IG | Market Commentary: Steel Dynamics, Quest Diagnostics, Welltower, BP Capital price; Apollo markets dollar notes
|
| 12/9/2019 | IG | New Issue: Quest Diagnostics prices $800 million of 2.95% notes due 2030 at 115 bps spread
|
| 12/9/2019 | BKIG | Moody’s rates Quest notes Baa2
|
| 12/9/2019 | IG | S&P assigns BBB+ to Quest notes
|
| 12/9/2019 | IG | Fitch gives Quest Diagnostics notes BBB
|
| 12/9/2019 | IG | Market Commentary: Morning Commentary: Steel Dynamics, Quest Diagnostics, Welltower on tap; light supply eyed
|
| 12/9/2019 | IG | Quest Diagnostics to price senior notes via five bookrunners
|
| 7/16/2019 | IG | Fitch affirms Quest Diagnostics
|
| 3/7/2019 | EMHYPFPV | Market Commentary: Quest sets terms for $500 million sale of notes due 2029; Marriott, Dell price deals
|
| 3/7/2019 | IG | Market Commentary: Quest sets terms for $500 million sale of notes due 2029; Marriott, Dell price deals
|
| 3/7/2019 | IG | New Issue: Quest Diagnostics sells $500 million 4.2% notes due 2029 at 160 bps over Treasuries
|
| 3/7/2019 | IG | Moody's rates Quest notes Baa2
|
| 3/7/2019 | IG | Fitch rates Quest notes BBB
|
| 3/7/2019 | IG | S&P rates Quest notes BBB+
|
| 3/7/2019 | IG | Market Commentary: Morning Commentary: Quest Diagnostics to price $500 million of notes; issuance slows
|
| 3/7/2019 | IG | Quest Diagnostics to price $500 million of 10-year senior notes
|
| 7/16/2018 | IG | DBRS lowers Inter Pipeline
|
| 7/16/2018 | IG | Fitch affirms Quest Diagnostics
|
| 12/13/2017 | SP | New Issue: Morgan Stanley sells $975,000 market-linked notes tied to 18 stocks
|
| 12/13/2017 | SP | New Issue: Morgan Stanley sells $510,000 market-linked notes tied to 18 stocks
|
| 5/23/2016 | EMHYMUPFPV | Market Commentary: Lam, Santander, Dominion, USAA, Quest among day’s issuers; credit spreads mostly flat
|
| 5/23/2016 | IG | Market Commentary: Lam Research, Santander, Dominion, USAA, Quest among day’s issuers; credit spreads mostly flat
|
| 5/23/2016 | IG | New Issue: Quest Diagnostics sells $500 million 3.45% 10-year notes at 165 bps over Treasuries
|
| 5/23/2016 | BKIG | S&P gives BBB+ to Quest notes
|
| 5/23/2016 | BK | Quest Diagnostics to repay debt under revolver, receivables facility
|
| 5/23/2016 | CVIG | Moody’s rates Quest notes Baa2
|
| 5/23/2016 | CVIG | Fitch rates Quest notes BBB
|
| 5/23/2016 | IG | Quest Diagnostics to offer $500 million of 10-year senior notes
|
| 3/29/2016 | IGLM | Quest Diagnostics holders tender $266.86 million 6.95%, 5.75% notes
|
| 3/28/2016 | IGLM | Quest Diagnostics prices tender for $200 million of 6.95%, 5.75% notes
|
| 3/15/2016 | IGLM | Quest Diagnostics offers to buy $200 million of 6.95%, 5.75% notes
|
| 6/24/2015 | SP | New Issue: Deutsche Bank prices $309,400 trigger phoenix autocallables linked to Quest
|
| 6/17/2015 | SP | Deutsche Bank plans trigger phoenix autocallables linked to Quest
|
| 4/30/2015 | BKCVIG | S&P lifts Quest view to stable
|
| 4/10/2015 | IGLM | Quest Diagnostics redeems some 3.2% notes, all 5.45% and 6.4% notes
|
| 3/19/2015 | IGLM | Quest hits tender offer cap for 6.95%, 5.75% notes by early deadline
|
| 3/18/2015 | IGLM | Quest Diagnostics prices tender offers for 6.95% notes, 5.75% notes
|
| 3/5/2015 | IGLM | Quest Diagnostics tenders for $250 million of 6.95% notes, 5.75% notes
|
| 3/5/2015 | EMHYMUPFPV | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
| 3/5/2015 | IG | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
| 3/5/2015 | IG | New Issue: Quest Diagnostics sells $1.2 billion of notes in five-, 10-, 30-year tranches
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
| 3/5/2015 | IG | Moody’s gives Baa2 to Quest Diagnostics notes
|
| 3/5/2015 | BKIG | Fitch rates Quest bond BBB
|
| 3/5/2015 | BKIG | S&P rates Quest notes BBB+
|
| 3/5/2015 | IGLM | Quest Diagnostics tenders for $250 million of 6.95% notes, 5.75% notes
|
| 3/5/2015 | IG | Quest preps $1.2 billion of notes in five-, 10-, 30-year tranches; pricing Thursday
|
| 3/12/2014 | IG | Quest preps $600 million of senior notes in five-, 10-year tranches
|
| 3/12/2014 | BK | Quest to repay credit facility borrowings via notes offering proceeds
|
| 3/12/2014 | IG | Market Commentary: EnLink, Nomura price as week's total nears $30 billion; energy bonds tighten
|
| 3/12/2014 | BKCVIG | Fitch downgrades Quest
|
| 3/12/2014 | BKCVIG | S&P rates Quest notes BBB+
|
| 3/12/2014 | BKIG | Moody's gives Quest notes Baa2
|
| 3/12/2014 | IG | New Issue: Quest prices $600 million of senior notes in five-, 10-year tranches
|
| 1/23/2014 | BKCVIG | Fitch: Quest on negative watch
|
| 10/25/2013 | IG | S&P: Quest view to negative
|
| 2/22/2013 | CVIG | Fitch: Quest outlook stable
|
| 2/22/2012 | CVIG | Fitch affirms Quest
|
| 8/22/2011 | SP | New Issue: Barclays prices $300,000 8.3% reverse convertibles linked to Quest Diagnostics
|
| 3/25/2011 | IG | Correction: Quest Diagnostics' 10-year tranche of notes totaled $550 million
|
| 3/21/2011 | CVIG | S&P rates Quest notes BBB+
|
| 3/21/2011 | CVIG | Moody's: Quest notes Baa2
|
| 3/21/2011 | CVIG | Fitch rates Quest notes BBB+
|
| 3/21/2011 | IG | New Issue: Quest Diagnostics prices massive $1.25 billion deal in four parts
|
| 3/21/2011 | IG | Market Commentary: Upbeat tone leads SunTrust, KeyCorp, Quest, Daimler to primary; AT&T, telecom bonds widen
|
| 3/18/2011 | CVIG | Moody's: Quest unchanged
|
| 2/25/2011 | CVIG | Fitch cuts Quest to negative
|
| 2/24/2011 | CVIG | Moody's: Quest unchanged
|
| 2/2/2011 | CVIG | Fitch affirms Quest
|
| 2/1/2011 | CVIG | Moody's: Quest unaffected
|
| 8/11/2010 | CVIG | Fitch affirms Quest Diagnostics
|
| 6/17/2010 | IG | Quest Diagnostics files automatic shelf covering debt securities
|
| 2/9/2010 | IG | Moody's boosts Quest Diagnostics
|
| 1/25/2010 | BWIG | Quest Diagnostics to use cash for growth, enhancing shareholder value
|
| 11/20/2009 | IG | Quest Diagnostics receives tenders for 26.87% of 5.125% notes, 35.94% of 7.5% notes
|
| 11/17/2009 | IG | Quest prices tender offer for any and all of its 5.125%, 7.5% notes
|
| 11/16/2009 | IG | Market Commentary: Westpac, Progress, BBVA, Kellogg among issuers; new deals trade briskly, secondary volume light
|
| 11/13/2009 | IG | Market Commentary: Lockheed Martin, Thermo Fisher sell bonds; Universal eyes split-rated sale; new deals flat
|
| 11/12/2009 | IG | New Issue: Quest Diagnostics sells $750 million notes in 10-, 30-year tranches
|
| 11/12/2009 | IG | S&P rates Quest notes BBB+
|
| 11/12/2009 | IG | Fitch rates Quest notes BBB+
|
| 11/12/2009 | IG | Market Commentary: Quest Diagnostics, Zimmer, Raytheon, Waste Management among day's sales; spreads ease
|
| 9/21/2009 | IG | Moody's ups Quest outlook to positive
|
| 8/14/2009 | IG | Fitch rates Quest BBB+
|
| 6/17/2009 | IG | Quest completes tender for up to $200 million of 5.125%, 7.5% notes
|
| 6/12/2009 | IG | Quest prices tender offer for up to $200 million of 5.125%, 7.5% notes
|
| 6/9/2009 | IG | Quest Diagnostics sees significant opportunity to grow internationally
|
| 6/3/2009 | IG | Quest Diagnostics gives early tender results for 5.125%, 7.5% notes
|
| 5/19/2009 | HY | Quest Diagnostics tenders for up to $200 million 5 1/8% notes due 2010, 71/2% notes due 2011
|
| 4/15/2009 | IG | Moody's: Quest unaffected
|
| 7/2/2008 | IG | S&P lifts Quest Diagnostics outlook to stable
|
| 6/19/2007 | HY | Quest concludes tender for AmeriPath's 101/2% notes with $348 million response
|
| 6/5/2007 | HY | Quest Diagnostics sets pricing, gets consents for AmeriPath's 101/2% notes
|
| 5/31/2007 | SS | Quest Diagnostics completes acquisition of AmeriPath in deal valued at about $2 billion
|
| 5/30/2007 | SS | Quest Diagnostics to complete acquisition of AmeriPath on Thursday
|
| 5/21/2007 | HY | Quest Diagnostics tenders for AmeriPath's 101/2% notes
|
| 4/16/2007 | SS | Market Commentary: Sallie lags below deal; Quest off; Fremont firms; Innkeepers stock up but convertible slides; Cott up
|
| 4/16/2007 | SS | Quest Diagnostics to acquire AmeriPath in $2 billion transaction
|
| 5/19/2006 | BT | Quest Diagnostics to acquire Focus Diagnostics for $185 million
|
| 12/9/2005 | BT | Quest develops assay to diagnose cancer of unknown primary origin
|
| 12/9/2005 | BT | Quest: studies show new diagnostic assays for hematologic diseases are effective, less invasive
|
| 10/25/2005 | BTCV | Moody's rates Quest notes Baa2
|
| 10/24/2005 | BT | S&P rates Quest Diagnostics notes BBB+, ups some ratings
|
| 10/24/2005 | CV | S&P rates Quest Diagnostics note BBB+, ups some ratings
|
| 8/8/2005 | BT | Market Commentary: Isis declines on earnings, Lilly note conversion but 5.5% convert finds bids; Quest, LabOne higher
|
| 8/8/2005 | BTCV | S&P: Quest Diagnostics unaffected
|
| 7/22/2005 | BT | Market Commentary: Momenta gains at open, then goes south; Adams up against market; Durect convertibles up on buyback
|
| 12/15/2004 | CV | Quest Diagnostics calls all $250 million 13/4% contingent convertibles
|
| 10/28/2004 | BKHY | S&P: Four health care firms unaffected
|
| 3/9/2004 | CV | Moody's ups Quest Diagnostics
|
| 7/28/2003 | CV | S&P rates new Health Management convertible
|
| 5/13/2003 | CV | S&P ups Quest Diagnostics
|
| 3/7/2003 | HY | Freeport-McMoRan tenders for 7.20% '26 and 7.50% '06 notes
|
| 3/5/2003 | HY | Camuzzi offers to purchase IEBA defaulted notes for cash
|
| 2/27/2003 | HY | Peabody Energy tenders for 8 7/8% and 9 5/8% '08 notes
|
| 2/21/2003 | HY | Netia calls 10% '08 notes for redemption
|
| 2/6/2003 | HY | Quest Diagnostics tenders for Unilab 123/4% '09 notes
|
| 12/20/2002 | CV | Market Commentary: Market quietly closes ahead of holiday-shortened weeks
|
| 6/5/2002 | BK | Moody's adjusts Adelphia's ratings
|
| 6/5/2002 | CV | Moody's adjusts Adelphia's ratings
|
| 5/29/2002 | BK | Moody's rates Quest Diagnostics' loan Baa3; upgrades other ratings
|
| 5/29/2002 | CV | S&P ups Union Pacific to BBB
|
| 5/29/2002 | HY | Moody's rates Quest Diagnostics' loan Baa3; upgrades other ratings
|
| 5/13/2002 | BK | Quest Diagnostics repays $100 million under revolver
|
| 4/19/2002 | CV | Market Commentary: Quiet session ends flat, lower for the week
|
| 4/2/2002 | CV | Moody's cuts Calpine convertibles to B1
|
| 4/2/2002 | CVHY | Quest Diagnostics obtains commitment on $550 million bridge loan for Unilab acquisition
|
| 4/2/2002 | HY | Moody's downgrades Calpine
|
| 2/11/2002 | HY | Moody's rates American Media new notes B2, outlook negative
|
| 2/11/2002 | CV | S&P revises WorldCom outlook to negative
|
| 2/8/2002 | CV | Market Commentary: Convertibles still thin, but get lift from late stock rally
|
| 12/4/2001 | CV | S&P ups Affiliated Computer subordinated notes
|
| 11/29/2001 | CVHY | Quest Diagnostics adds $250 million to debt, preferred, stock shelf for $650 million
|
| 11/27/2001 | CV | Quest Diagnostics says greenshoe exercised, raising convertibles to $250 million
|
| 11/26/2001 | CV | Market Commentary: Convertible market gains on positive retail sales, chip forecasts
|
| 11/20/2001 | CV | Market Commentary: Convertible market holds flat against stock retreat with new deal activity
|
| 11/19/2001 | CV | New Issue: Quest Diagnostics sells $225 million convertibles at 1.75% yield, up 40%
|
| 11/19/2001 | CV | Moody's rates Quest Diagnostics new convertible at Ba1
|
| 11/19/2001 | CV | Market Commentary: Convertible market higher, thankful to get new deals early
|
